National Foundation for Cancer Research (NFCR)

Wrapping up our recap of the NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, we’re highlighting our second keynote speaker of the day, Dr. Siddhartha Mukherjee, whose insights captivated the audience. 🎤 We also showcased a special evening panel that brought together the entire cancer research ecosystem—cancer researchers, advocates, scientists, and more—all united in the mission to advance cancer research. To read the recap of the entire event, please head over to https://lnkd.in/eXYYv9SM #GSAC24 #NFCR #MakeCuresPossible #Cancer #Research | OncoDaily | Kristen Berset-Harris | Dennis Slamon | Margaret Foti | Olufunmilayo (Funmi) Olopade | Mohit Manrao

Continuing our recap of the NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, we’re excited to share moments from the 2024 AIM-HI Women’s Venture Competition Award Ceremony, the Innovative Oncology Company Showcase, and our insightful panel on Investment Perspectives on Innovative Oncology Companies. 📸✨ For a full event recap and more photos, visit https://lnkd.in/eXYYv9SM #Cancer #Research #CancerResearch #NFCR #GSAC24 | OncoDaily

We had an extraordinary celebration at the 2024 NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, where Dr. Dennis Slamon was honored with the prestigious 2024 Szent-Györgyi Prize for Progress in Cancer Research. Dr. Slamon delivered an inspiring recap of his stellar career and groundbreaking scientific contributions to over 190 attendees last Friday evening, October 18, in Washington, DC. His journey, which has profoundly shaped the field of precision medicine for breast cancer patients and saved countless lives, left everyone uplifted and motivated. The Szent-Györgyi Prize for Progress in Cancer Research, established in 2006 by the National Foundation for Cancer Research in honor of its co-founder, Albert Szent-Györgyi, M.D., Ph.D., recipient of the 1937 Nobel Prize for Physiology and Medicine, recognizes outstanding scientists whose seminal discoveries or pioneering bodies of work have significantly contributed to cancer prevention, diagnosis, or treatment. This award celebrates those whose efforts have had a lasting impact on our understanding of cancer and improving or saving the lives of cancer patients. I am immensely proud that NFCR has played a pivotal role in recognizing these remarkable individuals with the Szent-Györgyi Prize for Progress in Cancer Research for the last 19 years. I cherish the vivid and beautiful memories of these iconic cancer research leaders. It was heartening to see previous Szent-Györgyi Prize winners, Drs. Web Cavenee, Carlo Croce, Susan Horwitz, Doug Lowy, Rakesh Jain, and Isaac Witz return to join us. Following his address, Dr. Slamon participated in a visionary panel discussion on the Future of Cancer Research, alongside Pulitzer Prize-winning author and cancer researcher Dr. Siddhartha Mukherjee, 2024 AIM-HI Beacon Award winner Dr. Margaret Foti, Fellow Selection Committee member Dr. Olufunmilayo (Funmi) Olopade, AstraZeneca business leader Mohit Manrao, and cancer patient advocates Shereen Pavlides and Isabella Pavlides. The Summit and award ceremonies received numerous congratulatory and heartwarming comments from attendees, who found the event uniquely inspiring. They appreciated the opportunity to learn about the latest advancements in cancer research and witness how experts and leaders from research, healthcare, pharmaceuticals, and investment sectors can collaborate, discuss, and strategize on advancing cancer care. The focus on big-picture views and forward-thinking was exceptional! Attendees were captivated by the insightful, proactive, and inspiring discussions of a constellation of shining stars under one roof. They loved the blend of hard science, poignant oncology stories, and celebratory dinners. I look forward to seeing you at the 2025 NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship on Friday, October 24, 2025, in Washington, DC, if not sooner! OncoDaily National Foundation for Cancer Research (NFCR)

Continuing our recap series of the NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, today we’re highlighting our first keynote speaker, Drew Pardoll, M.D., Ph.D., Director of the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University School of Medicine. 🎤 Dr. Pardoll set the stage for a powerful day, followed by two impactful panels: New Approaches to Cancer Treatments and Early Detection and Cancer Prevention. Stay tuned as we continue to share insights and moments from an inspiring event dedicated to advancing cancer research. 🔬✨ The full recap of the event is now live on: https://lnkd.in/eXYYv9SM The event began with a keynote address from Drew Pardoll, M.D., Ph.D. (Johns Hopkins University Medical School), who discussed the transformative impact of checkpoint inhibitors on cancer immunotherapies. Dr. Pardoll addressed the urgent need for biomarkers to predict patient responses, improved clinical trials, and emphasized the need for better combination therapies to make immunotherapy more effective for a broader range of cancer patients. Panel on New Approaches to Cancer Treatments During this panel, moderated by Lisa Coussens, Ph.D. (Oregon Health & Science University) innovative ideas and emerging areas in cancer treatment were discussed, with a strong emphasis on the critical need for personalized approaches. The session helped create a clear action plan for advancing research and developing new treatment strategies. Panel on Early Detection and Cancer Prevention Carlos Doti, M.D. of AstraZeneca, moderated this panel of key leaders to explore current unmet needs, emerging technologies, clinical and policy challenges of implementing cancer screening, and potential strategies that could significantly improve patient outcomes. #Cancer #Research #Recap #GSAC24 #NFCR | OncoDaily | Carlos Doti | Drew Pardoll

Kicking off our recap series of the NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, we are proud to highlight our two award winners, Dr. Dennis Slamon and Dr. Margaret Foti. 🎉 Stay tuned as we roll out daily posts over the next few days, featuring key moments from the event and a selection of photos capturing the incredible day. 📸 Be sure to check back for insights and highlights as we celebrate the strides made in cancer research! #GSAC24 #Cancer #Research #NFCR #MakeCuresPossible | OncoDaily

One last huge thank you to our Platinum level sponsor AstraZeneca, and our Gold level sponsor American Association for Cancer Research (AACR), for sponsoring the NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship! Without your support, Friday's unforgettable event would not have been possible! #GSAC24 #Cancer #nfcrglobalsummit #Research #CancerResearch #WashingtonDC #NonProfit

We proudly congratulate NFCR-Supported Dr. Lisa Coussens of Oregon Health & Science University for her recent election to the National Academy of Medicine, one of the highest honors in the health and medicine field. Dr. Coussens is widely respected for her expertise in cancer research, including breast cancer, immunotherapy, genomic biomarkers, and more. NFCR believes the researchers we support are among those who will make a cure for cancer possible, and Dr. Coussens is no exception. Please join us in congratulating Dr. Coussens on her exceptional commitment to advancing breakthroughs in cancer research. #NAM #CancerLeaders #WomenLeaders #WeMakeCuresPossible #TeamNFCR

We were honored to present Dr. Margaret Foti, CEO of the American Association for Cancer Research (AACR), with the 2024 AIM-HI Beacon Award for Women Leaders in Oncology at our Global Summit. Her relentless dedication and groundbreaking leadership continue to inspire us all in the fight against cancer. Congratulations, Dr. Foti, on this well-deserved recognition! We are proud to stand alongside such remarkable leaders making a lasting impact in oncology. #CancerResearch #BeaconAward #WomenInScience #GlobalSummit #GSAC24 #NFCR #MakeCuresPossible AIM-HI Accelerator Fund

Thank you everyone for attending this year's NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship! Mark your calendar's for next year's event!

Join us in Congratulating Dr. Dennis Slamon on being selected as the 2024 Szent-Györgyi Prize Winner! Dr. Slamon's research is responsible for saving countless lives, and it is an honor to recognize him. #GSAC24 #Prize #Award #Congratulations #Cancer #Research #CancerResearch | UCLA Health